Research with Human Participation and Consent:

When research involves human participants, authors must disclose the approving committee for the research and confirm adherence to the Code of Ethics (Declaration of Helsinki). Authors should include a statement in their manuscript affirming that informed consent has been obtained from all participants. The disclosure of information about research participants must adhere to laws regarding confidentiality and security of personal data, especially following GDPR (EU) 2016/679 regulations. The editorial board reserves the right to request documentary evidence from authors to confirm consent, including blank consent forms and documents from ethics boards. In cases involving vulnerable groups categorized by race, ethnicity, gender, disability, disease, etc., additional verification may be necessary, along with justifications in the manuscript for such categorizations.

Use of Images Relating to Individuals:

When using images related to individuals for visual representation:

• Individuals must be informed about the use of their image in the manuscript and its purpose, and written consent must be obtained.
• For minors, consent from their parents or guardians is mandatory.
• Captions and associated text should respect the dignity of the individuals depicted and maintain respect.
• Identifiable information and images should not be used without explicit consent.
• Authors must guarantee that any changes preserving anonymity do not distort the scientific meaning.
• Avoid using personal identifying information, ensuring anonymity and privacy.
• If identifiable images are used, a statement confirming informed consent is required.

Research Involving Human Embryos, Gametes, and Stem Cells:

Manuscripts involving such studies should confirm adherence to relevant guidelines and regulations. Ethics statements should specify approval from institutional/licensing committees and informed consent from recipients and/or donors of cells or tissues, describing donation conditions. The editorial board may request relevant document copies.

Human Biological Samples:

Authors describing human biological samples should refer to the BRISQ reporting guidelines to ensure proper characterization. At least a Level 1 characterization should be provided.

Clinical Trials Registration:

Prospective clinical trials must be registered before patient registration in a public repository, specifically for trials primarily determining pharmacokinetics.

Animal Research:

Animal experiments must comply with ARRIVE guidelines and EU Directive 2010/63/EU on the protection of animals used for scientific purposes. Manuscripts reporting animal studies should include details on institutional/licensing committee approval and conditions affecting animal results.

Experiments with Plants or Microorganisms:

Authors should provide botanical identity details, including scientific and common names, for commercially available cultivars and cultivated medicinal plants. Selection of medicinal plants should align with national pharmacopoeia or authoritative national documents. Experiments involving imported plants or microorganisms should be conducted with appropriate permits.

Presentation of Experimental Data:

Authors should ensure accurate and comprehensive presentation of experimental data, processing procedures, results, and statistical methods. Manuscripts must describe each dataset used and provide reproducible results. Manuscripts without evidence of result reproducibility will not be considered.